Thursday March 28, 2024 | Last Update: March 28, 2024 EDT
Lannett Company, Inc. has announced that it will be acquiring Kremers Urban Pharmaceuticals Inc., the U.S. specialty generic pharmaceuticals subsidiary of global biopharmaceuticals company UCB S.A. for $1.23 billion, according to a press release issued by Lannett.
Read more >>
Just In
Most Read
1